JOURNAVX, THE NEW NON-OPIOID PAINKILLER Ten days ago, the Food and Drug Administration approved a new type of painkiller that doesn’t carry the risk of addiction associated with opioid medications. Suzetrigine, the drug, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years. This is great news to us seniors, especially those who suffer from moderate-to-severe pain. Here are highlights from the January 30, 2025 WashingtonPost.com article by Daniel Gilbert and Rachel Roubein, FDA approves new non-opioid painkiller Journavx. The drug represents the first new class of...